Lindbrook Capital’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.22K Sell
657
-1,124
-63% -$10K ﹤0.01% 2023
2024
Q4
$16.9K Buy
1,781
+335
+23% +$2.94K ﹤0.01% 1377
2024
Q3
$11.8K Sell
1,446
-267
-16% -$2.77K ﹤0.01% 1575
2024
Q2
$23.2K Buy
1,713
+498
+41% +$4.16K ﹤0.01% 1159
2024
Q1
$8.52K Sell
1,215
-878
-42% -$7.62K ﹤0.01% 1656
2023
Q4
$22.9K Buy
2,093
+484
+30% +$4.75K ﹤0.01% 1108
2023
Q3
$17.7K Buy
1,609
+273
+20% +$3.9K ﹤0.01% 1115
2023
Q2
$21.1K Hold
1,336
﹤0.01% 1065
2023
Q1
$17.4K Buy
1,336
+176
+15% +$1.45K ﹤0.01% 1143
2022
Q4
$12.6K Sell
1,160
-111
-9% -$1.37K ﹤0.01% 1312
2022
Q3
$20K Buy
1,271
+128
+11% +$1.89K ﹤0.01% 977
2022
Q2
$9K Hold
1,143
﹤0.01% 1287
2022
Q1
$14K Buy
+1,143
New +$16K ﹤0.01% 1151

Other funds holding ENVX

Lindbrook Capital's ENVX Position: Q1 2025 in Review

Lindbrook Capital reduced its Enovix (ENVX) stake by 63% in Q1 2025, selling an estimated $10K and leaving 657 shares worth $4.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2023.

Lindbrook Capital first reported a position in ENVX in Q1 2022 and has held it in 13 quarters since. The position peaked at $23.2K in Q2 2024. 315 funds tracked by Wall St. Rank hold ENVX as of Q1 2025.

  • Lindbrook Capital held 657 shares of Enovix worth $4.22K as of Q1 2025.
  • Lindbrook Capital sold 1,124 Enovix shares in Q1 2025, an estimated $10K.
  • Enovix made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2023 holding.
  • Lindbrook Capital first reported a position in Enovix in Q1 2022 and has held it in 13 quarters since.
  • Lindbrook Capital's Enovix position peaked at $23.2K in Q2 2024.
  • 315 funds tracked by Wall St. Rank held Enovix as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.